Rim Frikha (R Frikha)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

The Libyan journal of medicine

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Rim Frikha
Lack of Impact of the A1298C MTHFR on the Risk of Childhood Acute Lymphoblastic Leukemia: Evidence from a Meta-analysis. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 38 (2) (2021)
Rim Frikha, Olfa Kassar, Moez Elloumi, Hassen Kamoun
Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
N Louati, F Turki, H Mnif, Rim Frikha
MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (1) (2021)
Rim Frikha, Fatma Turki, Olfa Kassar, Moez Elloumi, Hassen Kamoun
Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (7) (2021)
Rim Frikha, Moez Elloumi, Tarek Rebai, Hassen Kamoun
MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Rim Frikha, Maha Ben Jemaa, Fakher Frikha, Ines Turki, Moez Elloumi, Leila Keskes, Hassen Kamoun, Tarek Rebai
Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (6) (2020)
Mohamed Ali Rebai, Nizar Sahnoun, Oussema Abdelhedi, Khaled Keskes, Slim Charfi, Fathia Slimi, Rim Frikha, Hassib Keskes
Animal models of osteoarthritis: characterization of a model induced by Mono-Iodo-Acetate injected in rabbits. The Libyan journal of medicine 15 (1) (2020)
Rim Frikha
Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (7) (2020)
Rim Frikha, Tarek Rebai, Ben Mahmoud Lobna, Fakher Frikha, Moez Mdhaffar, Imen Frikha, Moez Elloumi, Nouha Bouayed
Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (5) (2018)
Rim Frikha, Nouha Bouayed, Bochra Ben Rhouma, Leila Keskes, Tarek Rebai
A duplex polymerase chain reaction-restriction fragment length polymorphism for rapid screening of methylenetetrahydrofolate reductase gene variants: Genotyping in acute leukemia. Journal of clinical laboratory analysis 32 (1) (2017)